Rasha Z Batran

6PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 14, 2026
Design, synthesis, anticancer activity and molecular modeling of new pyrazoline derivatives as telomerase inhibitors.

|Sep 15, 2025
Design, synthesis and molecular modeling of new coumarin-thiazole derivatives as dual EGFR/HDAC1 inhibitors: <i>in vitro</i> and <i>in vivo</i> anticancer assays.

Eman Y Ahmed, Mai M Elghonemy, Rasha Z Batran

|Jul 16, 2024
Naturally based pyrazoline derivatives as aminopeptidase N, VEGFR2 and MMP9 inhibitors: design, synthesis and molecular modeling.

Rasha Z Batran, Eman Y Ahmed, Hanem M Awad

|Jul 10, 2024
Design, synthesis and computational studies of new azaheterocyclic coumarin derivatives as anti-<i>Mycobacterium tuberculosis</i> agents targeting enoyl acyl carrier protein reductase (InhA).

Rasha Z Batran, Ahmed Sabt, Jarosław Dziadek

|Feb 19, 2024
New pyrazolylindolin-2-one based coumarin derivatives as anti-melanoma agents: design, synthesis, dual BRAF<sup>V600E</sup>/VEGFR-2 inhibition, and computational studies.

Ahmed Sabt, Mohammed A Khedr, Wagdy M Eldehna

|Aug 09, 2017
New Coumarin Derivatives as Anti-Breast and Anti-Cervical Cancer Agents Targeting VEGFR-2 and p38α MAPK.

Rasha Z Batran, Dina H Dawood, Samia A El-Seginy

Pageof 1

Frequent Collaborators

3 joint publications

Eman Y Ahmed

3 joint publications

Hanem M Awad

2 joint publications

Ahmed Sabt

1 joint publications

Mohammed A Khedr